Distinct functions of COX-1 and COX-2

Prostaglandins & Other Lipid Mediators - Tập 68-69 - Trang 165-175 - 2002
Ikuo Morita1
1Department of Cellular Physiological Chemistry, Graduate School, Tokyo Medical and Dental University, Japan. [email protected]

Tóm tắt

Từ khóa


Tài liệu tham khảo

Weissmann, 1993, Prostaglandins as modulators rather than mediators of inflammation, J. Lipid Med., 6, 275

Raisz, 1995, Physiologic and pathologic roles of prostaglandins and other eicosanoids in bone metabolism, J Nutr., 125, 2024S, 10.1093/jn/125.suppl_7.2024S

Richards, 1998, Molecular mechanisms of ovulation and luteinization, Mol. Cell Endocrinol., 145, 47, 10.1016/S0303-7207(98)00168-3

Williams, 1999, The role of cyclooxygenases in inflammation, cancer, and development, Oncogene, 18, 7908, 10.1038/sj.onc.1203286

Kraemer, 1992, Prostaglandin endoperoxide synthase gene structure: identification of the transcriptional start site and 5′-flanking regulatory sequences, Arch. Biochem. Biophys., 293, 391, 10.1016/0003-9861(92)90411-O

Vane, 1998, Mechanism of action of nonsteroidal anti-inflammatory drugs, Am. J. Med., 104, 2S, 10.1016/S0002-9343(97)00203-9

Smith, 1993, Differentiation of monocytoid THP-1 cells with phorbol ester induces expression of prostaglandin endoperoxide synthase-1 (COX-1), Biochem. Biophys. Res. Commun., 192, 787, 10.1006/bbrc.1993.1483

Kitzler, 1995, Analysis and quantitation of splicing variants of the TPA-inducible PGHS-1 mRNA in rat tracheal epithelial cells, Arch. Biochem. Biophys., 316, 856, 10.1006/abbi.1995.1115

Murakami, 1995, C-kit ligand mediates increased expression of cytosolic phospholipase A2, prostaglandin endoperoxide synthase-1, and hematopoietic prostaglandin D2 synthase and increased IgE-dependent prostaglandin D2 generation in immature mouse mast cells, J. Biol. Chem., 270, 3239, 10.1074/jbc.270.7.3239

Ueda, 1997, Induction of cyclooxygenase-1 in a human megakaryoblastic cell line (CMK) differentiated by phorbol ester, Biochim. Biophys. Acta, 1344, 103, 10.1016/S0005-2760(96)00131-2

Okahara, 1998, Upregulation of prostacyclin synthesis-related gene expression by shear stress in vascular endothelial cells, Arteriol. Thromb. Vascul. Biol., 18, 1922, 10.1161/01.ATV.18.12.1922

Bryant, 1998, Vascular endothelial growth factor upregulates constitutive cyclooxygenase-1 in primary bovine and human endothelial cells, Life Sci., 62, 2195, 10.1016/S0024-3205(98)00197-0

Diaz, 1998, Differential regulation of cyclooxygenases-1 and -2 by interleukin-1 beta, tumor necrosis factor-alpha, and transforming growth factor-beta 1 in human lung fibroblasts, Exp. Cell Res., 241, 222, 10.1006/excr.1998.4050

Forwood, 1998, Localisation of prostaglandin endoperoxide H synthase (PGHS)-1 and PGHS-2 in bone following mechanical loading in vivo, Anat. Rec., 252, 580, 10.1002/(SICI)1097-0185(199812)252:4<580::AID-AR8>3.0.CO;2-S

Jun, 1998, Estrogen upregulates cyclooxygenase-1 gene expression in ovine fetal pulmonary artery endothelium, J. Clin. Invest., 102, 176, 10.1172/JCI2034

Bogar, 1999, Enhanced bradykinin-stimulated prostaglandin release in the acutely inflamed guinea pig gallbladder is due to new synthesis of cyclooxygenase-1 and prostacyclin synthase, J. Surg. Res., 84, 71, 10.1006/jsre.1999.5612

Onodera, 1999, High molecular hyaluronic acid inhibited angiogenesis and IL-1-induced PGE2 production in synovial cells isolated from rheumatoid arthritis, Mediat. Inflam., 8, S19

Wang J, Morita I, Onodera M, Murota S [unpublished data].

Xu, 1997, Involvement of two Sp1 elements in basal endothelial prostaglandin H synthase-1 promoter activity, J. Biol. Chem., 272, 6943, 10.1074/jbc.272.11.6943

Alroy, 1999, Neu differentiation factor stimulates phosphorylation and activation of the Sp1 transcription factor, Mol. Cell Biol., 19, 1961, 10.1128/MCB.19.3.1961

Krikun, 2000, Regulation of tissue factor gene expression in human endometrium by transcription factors Sp1 and Sp3, Mol. Endocrinol., 14, 393, 10.1210/mend.14.3.0430

Chen, 2000, Functional interaction between c-jun and promoter factor Sp1 in epidermal growth factor-induced gene expression of human 12(S)-lipoxygenase, Proc. Natl. Acad. Sci. U.S.A., 97, 10406, 10.1073/pnas.180321497

Tanabe T, Tohnai N. Cyclooxygenase isozymes and their gene structures and expression. Prostagland Lipid Mediat 2000;68–9:95–114.

Niiro, 1997, Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils, Blood, 89, 1621, 10.1182/blood.V89.5.1621

Migita, 2000, FK506 augments glucocorticoid-mediated cyclooxygenase-2 downregulation in human rheumatoid synovial fibroblasts, Lab. Invest., 80, 135, 10.1038/labinvest.3780017

Gonzalez, 2000, Glucocorticoids antagonize AP-1 by inhibiting the activation/phosphorylation of JNK without affecting its subcellular distribution, J. Cell Biol., 150, 1199, 10.1083/jcb.150.5.1199

Boerboom, 1998, Molecular characterization of equine prostaglandin G/H synthase-2 and regulation of its messenger ribonucleic acid in preovulatory follicles, Endocrinology, 139, 1662, 10.1210/endo.139.4.5898

Gierse, 1996, A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors, J. Biol. Chem., 271, 15810, 10.1074/jbc.271.26.15810

Habeeb, 2001, Design and synthesis of celecoxib and rofecoxib analogues as selective cyclooxygenase-2 (COX-2) inhibitors: replacement of sulfonamide and methylsulfonyl pharmacophores by an azido bioisostere, J. Med. Chem., 44, 3039, 10.1021/jm010153c

Bhattacharyya, 1995, Selective inhibition of prostaglandin endoperoxide synthase-1 (cyclooxygenase-1) by valerylsalicylic acid, Arch. Biochem. Biophys., 317, 19, 10.1006/abbi.1995.1130

Laneuville, 1995, Fatty acid substrate specificities of human prostaglandin endoperoxide H synthase-1 and -2. Formation of 12-hydroxy-(9Z, 13E/Z, 15Z)- octadecatrienoic acids from alpha-linolenic acid, J. Biol. Chem., 270, 19330, 10.1074/jbc.270.33.19330

Smith, 1996, Prostaglandin endoperoxide H synthases-1 and -2, Adv. Immunol., 62, 167, 10.1016/S0065-2776(08)60430-7

Shitashige, 1998, Different substrate utilization between prostaglandin endoperoxide H synthase-1 and -2 in NIH3T3 fibroblasts, Biochim. Biophys. Acta, 1389, 57, 10.1016/S0005-2760(97)00129-X

Morita, 1995, Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2, J. Biol. Chem., 270, 10902, 10.1074/jbc.270.18.10902

Schievella, 1995, Calcium-mediated translocation of cytosolic phospholipase A2 to the nuclear envelope and endoplasmic reticulum, J. Biol. Chem., 270, 30749, 10.1074/jbc.270.51.30749

Murakami, 1999, J. Biol. Chem., 274, 31435, 10.1074/jbc.274.44.31435

Chen, 1999, Hydroperoxide dependence and cooperative cyclooxygenase kinetics in prostaglandin H synthase-1 and -2, J. Biol. Chem., 274, 20301, 10.1074/jbc.274.29.20301

Kulmacz, 1994, Interaction between peroxidase and cyclooxygenase activities in prostaglandin endoperoxide synthase. Interpretation of reaction kinetics, J. Biol. Chem., 269, 5527, 10.1016/S0021-9258(17)37493-8

Capdevila, 1995, The catalytic outcomes of the constitutive and the mitogen inducible isoforms of prostaglandin H2 synthase are markedly affected by glutathione and glutathione peroxidase(s), Biochemistry, 34, 3325, 10.1021/bi00010a023

Kulmacz, 1995, Comparison of hydroperoxide initiator requirements for the cyclooxygenase activities of prostaglandin H synthase-1 and -2, J. Biol. Chem., 270, 24019, 10.1074/jbc.270.41.24019

Langenbach, 1995, Prostaglandin synthase-1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration, Cell, 83, 483, 10.1016/0092-8674(95)90126-4

Reese, 2001, Comparative analysis of pharmacologic and/or genetic disruption of cyclooxygenase-1 and cyclooxygenase-2 function in female reproduction in mice, Endocrinology, 142, 3198, 10.1210/endo.142.7.8307

Houchen, 2000, Disruption of cyclooxygenase-1 gene results in an impaired response to radiation injury, Am. J. Physiol., 279, G858

Morham, 1995, Prostaglandin synthase-2 gene disruption causes severe renal pathology in the mouse, Cell, 83, 473, 10.1016/0092-8674(95)90125-6

Dinchuk, 1995, Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II, Nature, 378, 406, 10.1038/378406a0

Iadecola, 2001, Reduced susceptibility to ischemic brain injury and N-methyl-d-aspartate-mediated neurotoxicity in cyclooxygenase-2 deficient mice, Proc. Natl. Acad. Sci. U.S.A., 98, 1294, 10.1073/pnas.98.3.1294

Oshima, 1996, Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase-2 (COX-2), Cell, 87, 803, 10.1016/S0092-8674(00)81988-1

Cheng, 2001, Genetic deletion of COX-2 prevents increased renin expression in response to ACE inhibition, Am. J. Physiol., 280, F449

Langenbach, 1999, Cyclooxygenase deficient mice. A summary of their characteristics and susceptibilities to inflammation and carcinogenesis, Ann. N. Y. Acad. Sci., 889, 52, 10.1111/j.1749-6632.1999.tb08723.x

Zhang, 1999, Malignant transformation and anti-neoplastic actions of nonsteroidal anti-inflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts, J. Exp. Med., 190, 451, 10.1084/jem.190.4.451

Loftin, 2001, Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2, Proc. Natl. Acad. Sci. U.S.A., 98, 1059, 10.1073/pnas.98.3.1059

Smith, 2000, Cyclooxygenases: structural, cellular, and molecular biology, Ann. Rev. Biochem., 69, 145, 10.1146/annurev.biochem.69.1.145

Hartner, 2000, Upregulation of cyclooxygenase-1 and the PGE2 receptor EP2 in rat and human mesangioproliferative glomerulonephritis, Inflam. Res., 49, 345, 10.1007/PL00000215

Sato, 1996, Involvement of prostaglandin endoperoxide H synthase-2 in osteoclast-like cell formation induced by interleukin-1 beta, J. Bone Min. Res., 11, 392, 10.1002/jbmr.5650110313

Geng, 1995, Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes, J. Immunol., 155, 796, 10.4049/jimmunol.155.2.796

Hempel, 1994, Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes, J. Clin. Invest., 93, 391, 10.1172/JCI116971

Wollheim, 2001, Approaches to rheumatoid arthritis in 2000, Curr. Opin. Rheumatol., 13, 193, 10.1097/00002281-200105000-00008

Samad, 2001, Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity, Nature, 410, 471, 10.1038/35068566

Jakobsson, 1999, Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target, Proc. Natl. Acad. Sci. U.S.A., 96, 7220, 10.1073/pnas.96.13.7220

Matijevic-Aleksic, 1995, Differential expression of thromboxane A synthase and prostaglandin H synthase in megakaryocytic cell line, Biochim. Biophys. Acta., 1269, 167, 10.1016/0167-4889(95)00116-A

Catella-Lawson, 1999, Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids, J. Pharmacol. Exp. Therap., 289, 735

Bombardier, 2000, VIGOR study group. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR study group, N. Engl. J. Med., 343, 1520, 10.1056/NEJM200011233432103

Silverstein, 2000, Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study, JAMA, 284, 1247, 10.1001/jama.284.10.1247

Qian, 1999, Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits, Circulation, 99, 2979, 10.1161/01.CIR.99.23.2979

Williams, 2001, Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention, Cancer Res., 61, 3285

Leach, 1998, Decline in the expression of copper/zinc superoxide dismutase in the kidney of rats with endotoxic shock: effects of the superoxide anion radical scavenger, tempol, on organ injury, Br. J. Pharmacol., 125, 817, 10.1038/sj.bjp.0702123

Asahara, 1999, Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization, Circ. Res., 85, 221, 10.1161/01.RES.85.3.221

Tsujii, 1998, Cyclooxygenase regulates angiogenesis induced by colon cancer cells, Cell, 93, 705, 10.1016/S0092-8674(00)81433-6

Tsujii, 1995, Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2, Cell, 83, 493, 10.1016/0092-8674(95)90127-2

Sheng, 1998, Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells, Cancer Res., 58, 362

Bamba, 2000, Effect of prostaglandin E1 on vascular endothelial growth factor production by human macrophages and colon cancer cells, J. Exp. Clin. Cancer Res., 19, 219

Majima, 2000, Cyclooxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants, Br. J. Pharmacol., 130, 641, 10.1038/sj.bjp.0703327

Komhoff, 1997, Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function, Am. J. Physiol., 272, F460

Nantel, 1999, Immunolocalization of cyclooxygenase-2 in the macula densa of human elderly, FEBS Lett., 457, 475, 10.1016/S0014-5793(99)01088-1